FDA Approves Novel Car T-Immunotherapy for the Treatment of Multiple Myeloma By Lee Greenberger, PhD, Chief Scientific Officer at LLS | March 27, 2021 Read More
FDA Approval of New Treatment Option for Children with Secondary Acute Myeloid Leukemia is a Welcome Step Forward By Gwen Nichols, MD, LLS Chief Medical Officer | March 31, 2021 Read More
Another First: FDA Approves Car T-Immunotherapy for Treatment of Aggressive Form of Indolent Non-Hodgkin Lymphoma By Lee Greenberger, PhD, Chief Scientific Officer at LLS | March 5, 2021 Read More
Meet Three Women in Science Championing Myeloma Cures and Care By LLS Staff | March 5, 2021 Read More
Two Prominent Themes of 2020 Make an Appearance at #ASH20: Covid-19 and Racial Disparities By Andrea Greif | December 5, 2020 Read More
Take Part in the Raise Hope, End Cancer Fundraiser with Walgreens By LLS Staff | February 4, 2021 Read More
Practicing Self-Advocacy During My PTCL Journey By Special Guest Contributor Aaron | January 12, 2021 By Special Guest Contributor Aaron | January, 2021 Read More
